Black Diamond Therapeutics Inc (BDTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,875 | -91,169 | -70,091 | -48,437 | -25,507 |
| Depreciation Amortization | 122 | 508 | 382 | 253 | 125 |
| Accounts payable and accrued liabilities | 1,169 | -2,230 | 1,653 | -1,885 | -2,224 |
| Other Working Capital | -2,785 | -9,901 | -5,238 | -6,849 | -7,511 |
| Other Operating Activity | 2,338 | 17,710 | 10,151 | 10,251 | 6,517 |
| Operating Cash Flow | $-20,031 | $-85,082 | $-63,143 | $-46,667 | $-28,600 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -183 | -192 | -200 | -7 |
| Purchase Of Investment | 0 | -60,141 | -36,454 | -20,504 | -20,504 |
| Sale Of Investment | 24,806 | 113,690 | 87,690 | 57,241 | 37,240 |
| Investing Cash Flow | $24,806 | $53,366 | $51,044 | $36,537 | $16,729 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 51 | 177 | 205 | 153 | 153 |
| Financing Cash Flow | $51 | $177 | $205 | $153 | $153 |
| Beginning Cash Position | 35,483 | 67,022 | 67,022 | 67,022 | 67,022 |
| End Cash Position | 40,309 | 35,483 | 55,128 | 57,045 | 55,304 |
| Net Cash Flow | $4,826 | $-31,539 | $-11,894 | $-9,977 | $-11,718 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,031 | -85,082 | -63,143 | -46,667 | -28,600 |
| Capital Expenditure | N/A | -192 | -192 | -200 | -7 |
| Free Cash Flow | -20,031 | -85,274 | -63,335 | -46,867 | -28,607 |